More
    Guided Solutions - Connecting Talent With Innovation/div>

    MMI completes first robotic-assisted procedure in Alzheimer’s patient

    Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study. REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI received FDA investigational device exemption (IDE) to conduct the study...

    MMI completes first robotic-assisted procedure in Alzheimer’s patient

    Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study. REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI...

    Apollo investment supports vVARDIS’s global Curodont expansion

    vVARDIS has announced a strategic minority investment from funds managed by Apollo, a global alternative asset management firm. The investment will support the company’s...

    FDA grants 510(k) clearance to TaeWoong Medical for Spaxus EUS stent

    US-based TaeWoong Medical has secured the US Food and Drug Administration (FDA) clearance to commercialise the Niti-S Spaxus Stent, expanding its range of endoscopic...

    CVRx enrolls first patient in study of Barostim therapy for heart failure

    CVRx announced that it enrolled the first patient in its landmark BENEFIT-HF study of its Barostim therapy. Barostim delivers electrical pulses to baroreceptors in the...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    MMI completes first robotic-assisted procedure in Alzheimer’s patient

    Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study. REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI...

    CVRx enrolls first patient in study of Barostim therapy for heart failure

    CVRx announced that it enrolled the first patient in its landmark BENEFIT-HF study of its Barostim therapy. Barostim delivers electrical pulses to baroreceptors in the...

    Sensome reports positive findings for clot-sensing guidewire

    Sensome announced the publication of first-in-human results from the CLOT OUT study evaluating its Clotild smart guidewire system. Findings published in the Journal of Neurointerventional...

    CorTec’s Brain Interchange BCI system enables stroke patient to control computer with his mind

    CorTec GmbH announced that the first participant in the University of Washington’s NIH-funded clinical trial of the Brain Interchange™ BCI system has successfully controlled...

    Innovation

    Regulatory Approvals

    MMI completes first robotic-assisted procedure in Alzheimer’s patient

    Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study. REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI...

    Apollo investment supports vVARDIS’s global Curodont expansion

    vVARDIS has announced a strategic minority investment from funds managed by Apollo, a global alternative asset management firm. The investment will support the company’s...

    FDA grants 510(k) clearance to TaeWoong Medical for Spaxus EUS stent

    US-based TaeWoong Medical has secured the US Food and Drug Administration (FDA) clearance to commercialise the Niti-S Spaxus Stent, expanding its range of endoscopic...

    CVRx enrolls first patient in study of Barostim therapy for heart failure

    CVRx announced that it enrolled the first patient in its landmark BENEFIT-HF study of its Barostim therapy. Barostim delivers electrical pulses to baroreceptors in the...

    M&A

    Archives

    Latest articles